Bright Green (Bright Green) Float Percentage Of Total Shares Outstanding : 39.86% (As of Apr. 27, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bright Green Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bright Green's float shares is 75.79 Mil. Bright Green's total shares outstanding is 190.17 Mil. Bright Green's float percentage of total shares outstanding is 39.86%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bright Green's Insider Ownership is 53.42%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bright Green's Institutional Ownership is 4.70%.

Bright Green Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Bright Green's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	75.79	/	190.17
	=	39.86%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bright Green (Bright Green) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (NAS:BGXX) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1033 George Hanosh Boulevard, Grants, NM, USA, 87020

Website

https://www.brightgreen.us

Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).

Executives

Gurvinder Singh	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Saleem Elmasri	officer: Chief Financial Officer	450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Seamus Mcauley	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson	director, officer: Chief Executive Officer	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc.	10 percent owner	3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1